Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study

European Journal of Heart Failure

Volumn 7, Issue 1, 2005, Pages 127-135

  Shelton, Rhidian J ^a   Velavan, Periaswamy ^a   Nikitin, Nikolay P ^a   Coletta, Alison P ^a   Clark, Andrew L ^a   Rigby, Alan S ^a   Freemantle, Nick ^b   Cleland, John G F ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

A HeFT; ACORN CSD; CARP; CREATE; ESCAPE; GEMINI; PEACE; Primary care trial of chronic disease management; SCD HeFT cost effectiveness; SHIELD; Vitamin E meta analysis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ALTEPLASE; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GLUCOSE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; INOTROPIC AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL TARTRATE; PERINDOPRIL; POTASSIUM; RAMIPRIL; REVIPARIN; SPIRONOLACTONE; STREPTOKINASE; TENECTEPLASE; TRANDOLAPRIL;

ACUTE HEART INFARCTION; BRADYCARDIA; CARDIOVASCULAR DISEASE; CATHETERIZATION; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART VALVE SURGERY; HEART VENTRICLE TACHYCARDIA; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERTENSION; META ANALYSIS; METABOLIC REGULATION; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SAFETY; SHOCK; SIDE EFFECT; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; VITAMIN SUPPLEMENTATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; CATHETERIZATION, SWAN-GANZ; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; FIBRINOLYTIC AGENTS; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; HYPOGLYCEMIC AGENTS; MYOCARDIAL REVASCULARIZATION; PRIMARY HEALTH CARE; VITAMIN E;

EID: 11844290703     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.11.008     Document Type: Conference Paper

References (25)

1. D.L. Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, S.H. Kubo On behalf of the ACORN Investigators Rationale, design and methods for a pivotal randomised clinical trial for the assessment of a cardiac support device in patients with New York Heart association Class III-IV heart failure J. Card. Fail. 10 3 2004 185 192
2. A.A. Louis, T. Turner, M. Gretton, A. Baksh, and J.G.F. Cleland A systematic review of telemonitoring for the management of heart failure Eur. J. Heart Fail. 5 2003 583 590
3. J. Gonseth, P. Gullar-Castillon, J.R. Banegas, and Rodriguez-Artalejo The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports Eur. Heart J. 25 2004 1570 1595
4. K.F. Fox, M.R. Cowie, D.A. Wood, A.J. Coates, P.A. Poole-Wilson, and G.C. Sutton A rapid access heart failure clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community Eur. J. Heart Fail. 2 423 2000 429
5. S.P. Wright, H. Walsh, K.M. Ingley, S.A. Muncaster, G.D. Gamble, and A. Pearl Uptake of self-management strategies in a heart failure management programme Eur. J. Heart Fail. 5 2003 371 380
6. S. Yusuf, D. Zucker, P. Peduzzi, L.D. Fisher, T. Takaro, and J.W. Kennedy Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
7. The PEACE Trial Investigators Angiotensin converting enzyme inhibition in stable coronary artery disease N. Engl. J. Med. 351 2004 2058 2068
8. P. Svensson, U. de Faire, P. Sleight, S. Yusuf, and J. Stergren Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy Hypertension 38 2001 e28 e32
9. J.A. Franciosa, A.L. Taylor, J.N. Cohn, C.W. Yancy, S. Ziesche, A. Olukotun A-HeFT Investigators African-American Heart Failure Trial (A-HeFT): rationale, design and methodology J. Card. Fail. 8 3 2002 128 135
10. A.L. Taylor For the A-HeFT Trial Investigators Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N. Engl. J. Med. 351 2004 2049 2057
11. P. Carson For the V-HeFT Trial Study Group Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials J. Card. Fail. 5 3 1999 178 187
12. D.V. Exner, D.L. Dries, M.J. Domanski, and J.N. Cohn Lesser response to ACE inhibitor therapy in black as compared with white patients with left ventricular dysfunction N. Engl. J. Med. 344 2001 1351 1357 [Ref. ID 5269]
13. D.L. Dries, M.H. Strong, R. Cooper, and M.H. Drazner Efficacy of angiotensin converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients J. Am. Coll. Cardiol. 40 2002 311 317
14. C.W. Yancy For the US Carvedilol Heart Failure Study Group Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure N. Engl. J. Med. 344 2001 1358 1365
15. B.M. Massie, M. Packer, J.T. Hanlon, and D.T. Combs Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure J. Am. Coll. Cardiol. 2 1983 338 344
16. G.L. Bakris For the GEMINI Investigators Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension JAMA 292 18 2004 2227 2236
17. J. Refsgaard, C. Thomsen, F. Andreassen, and O. Gotzsche Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure Eur. J. Heart Fail. 4 2002 445 453
18. S. Nodari, M. Metra, A.D. Cas, and L.D. Cas Efficacy and tolerability of the long term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus Eur. J. Heart Fail. 5 2003 803 809
19. E.R. Miller, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, J.L. Appel, and E. Guallar Meta-analysis: high dose vitamin E supplementation may increase all-cause mortality Ann. Intern. Med. 142 2004 [in press]
20. M.A. Shah For the ESCAPE Investigators Evaluation study of congestive heart failure and pulmonary artery catheterisation effectiveness (ESCAPE): design and rationale Am. Heart J. 141 2001 528 535
21. E.A. Rose For the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long-term use of a left ventricular assist device for end-stage heart failure N. Engl. J. Med. 345 20 2001 1435 1443
22. E.O. McFalls, H.B. Ward, W.C. Krupski, S. Goldman, F. Littooy, and K. Eagle Prophylactic coronary artery revascularisation for elective vascular surgery: study design Control. Clin. Trials 20 1999 297 308
23. G.L. Pierpont, T.E. Mortiz, S. Goldman, W.C. Krupski, F. Littooy, H.B. Ward Current Opinion on Revascularisation Study Investigators Disparate opinions regarding indications for coronary artery revascularisation before elective vascular surgery Am. J. Cardiol. 94 9 2004 1124 1128
24. J.G.F. Cleland, J. Ghosh, N. Freemantle, G.C. Kaye, M. Nasir, and A.L. Clark Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronisation therapy in heart failure Eur. J. Heart Fail. 6 2004 501 508
25. A.D. Galbreath, R.A. Krasuski, B. Smith, K.C. Stajdhuhar, M.D. Kwan, and R. Ellis Long-term healthcare and cost outcomes of disease management in a large randomised community based population with heart failure Circulation 2004 110 [in press]